VANCOUVER, BC / ACCESSWIRE / September 8, 2017 / CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces that Jeremy Poirier has provided his resignation as a director of CVR Medical to pursue his other business interests. CVR Medical would like to thank Mr. Poirier for his contribution to the board of directors and wish him all the best in his future endeavours. Mr. Poirier will remain on as a consultant with the company.
Going forward, CVR Medical wishes to maintain a board size of five directors and therefore will not seek to replace Mr. Poirier’s seat.
For additional information on the organization, leadership, and current news please visit the newly launched company website www.CVRMed.com
About CVR Medical
CVR Medical is a company that is involved in an equal parts joint venture with CVR Global Inc. (the “Joint Venture”). The Joint Venture operates in the medical industry focused on the commercialization of a proprietary subsonic, infrasonic, and low frequency sound wave analysis technology and has patents to a diagnostic device designed to detect and measure carotid arterial stenosis. CVR Medical is managed by a proven technical team. CVR Medical trades on the TSX Venture Exchange under the symbol CVM.
For further information contact:
Brisco Capital Partners Corp.
Scott Koyich, President
Telephone: (403) 262-9888